What neurological conditions can cause sleep apnea?

Neurological Causes of Sleep Apnea

Neurological conditions cause sleep apnea through three primary mechanisms: brainstem respiratory control dysfunction leading to central sleep apnea, neuromuscular weakness causing both obstructive and central events, and cerebrovascular injury triggering Cheyne-Stokes respiration patterns.

Central Sleep Apnea from Brainstem Pathology

Structural brainstem lesions directly impair respiratory control centers, producing central apneas through disruption of chemoreceptor sensitivity and ventilatory drive. 1

• Microstructural damage in the brainstem, detectable by diffusion tensor imaging (DTI), correlates with central sleep apnea severity even when conventional MRI appears normal 1
• Cerebrovascular events (stroke) and other neurological disorders constitute a major etiologic category for Cheyne-Stokes respiration, often signaling severe central nervous system injury 2
• The pathophysiology involves post-hyperventilation hypocapnia that lowers arterial CO₂ below the apneic threshold during non-REM sleep, when the wakefulness drive to breathe is withdrawn 3, 2

Common pitfall: Standard structural MRI may miss subtle brainstem changes that cause central sleep apnea; advanced imaging techniques like DTI are more sensitive for detecting these microstructural abnormalities 1

Neuromuscular Disease-Related Sleep Apnea

Neuromuscular disorders produce a unique constellation of sleep-disordered breathing events including diaphragmatic/pseudo-central apneas, obstructive apneas, and hypoventilation. 4

• Respiratory muscle weakness combined with normal REM sleep atonia, reduced lung volumes, and impaired airway dilator activity creates compounding vulnerabilities 4
• The most commonly identified events are diaphragmatic/pseudo-central apneas, occurring due to decreased rib cage contribution to tidal volume during phasic REM sleep 4
• Disease-specific features that promote upper airway collapse or cause dilated cardiomyopathy further contribute to sleep-disordered breathing 4
• Pediatric neurological conditions commonly present with underrecognized sleep apnea that can independently alter disease presentation, severity, and course 5

Critical consideration: Noninvasive ventilation can paradoxically trigger additional sleep-disordered breathing events (ineffective triggering, autotriggering, central sleep apnea, glottic closure) and should be used cautiously in patients with dilated cardiomyopathy or significant bulbar symptoms 4

Central Nervous System Disorders Affecting Upper Airway Function

CNS disorders causing dysarthria and dysphagia can produce obstructive and central sleep apnea even without typical anatomic airway abnormalities. 6

• Abnormal upper airway reflex function, altered cortical arousal thresholds, and impaired motor control contribute to obstructive sleep apnea pathophysiology in neurological disease 7
• The supine position and sleep state further compromise already reduced lung volumes in neuromuscular disease, exaggerating upper airway collapse tendency 4

Specific High-Risk Neurological Conditions

Identify these neurological populations for sleep apnea screening:

• Cerebral microangiopathy and white matter disease (demonstrated in Fabry disease as a model) 1
• Stroke patients with Cheyne-Stokes respiration patterns 2
• Idiopathic intracranial hypertension (60% prevalence of OSA with AHI ≥5) 8
• Any neuromuscular disorder affecting respiratory muscles 4, 5
• CNS disorders with dysarthria, dysphagia, or bulbar symptoms 6

Diagnostic Approach

Polysomnography with specialized protocols is essential for accurate diagnosis and management in neurological patients. 4

• Standard sleep studies may misclassify events; esophageal pressure monitoring differentiates true central events from obstructive hypopneas 2
• Dedicated hypoventilation protocols and technical staff experienced in identifying neurologically-mediated respiratory events optimize diagnostic accuracy 4
• DTI brain imaging should be considered when central sleep apnea is present with suspected brainstem pathology, as it detects microstructural changes missed by conventional MRI 1

Treatment Considerations

Acetazolamide is conditionally recommended for central sleep apnea due to medical conditions or disorders, including neurological etiologies. 3

• The AASM suggests oral acetazolamide over no treatment for CSA due to medical conditions, though evidence certainty is low 3
• Transvenous phrenic nerve stimulation represents an alternative for primary CSA, but requires invasive procedures and may be more appropriate after considering other treatments first 3
• Noninvasive ventilation requires careful titration and monitoring in neurological patients due to risk of triggering additional sleep-disordered breathing events 4